Vertex PharmaceuticalsVRTX 
$474.16-1.48%24h
-1.48%24h
Global rank113
Market cap$122.19B
Change 7d-3.23%
YTD Performance17.08%
SP500 benchmarkUnderperform
P/E34.14
P/S12.38
Revenue$9.87B
Earnings$3.62B
Dividend yield-
Main Sector
Healthcare
Vertex Pharmaceuticals (VRTX) Total Liabilities
VRTX Total Liabilities in 2022: $5.15B
According to Vertex Pharmaceuticals latest financial reports the total liabilities of VRTX is $5.15B, an increase of 21.51% to 2022. At the end of 2022 company had $4.24B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Vertex Pharmaceuticals is responsible for during its operational activities.
Vertex Pharmaceuticals (VRTX) Total Liabilities History from 2023 to 2022
-
Value:-
VRTX Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $5.15B | 21.51% |
| 2022 | $4.24B | 27.18% |
| 2021 | $3.33B | 8.73% |
| 2020 | $3.06B | 37.25% |
| 2019 | $2.23B | 190.32% |
| 2018 | $769.22M | - |
View the Top Total Liabilies Stocks
